Sensorimotor gating and D 2 receptor signalling: Evidence from a molecular genetic approach

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1427-1440

  Völter, Christoph ^a   Riedel, Michael ^a,b   Wöstmann, Nicola ^a   Aichert, Désirée S ^a   Lobo, Sarah ^c   Costa, Anna ^a   Schmechtig, Anne ^c   Collier, David A ^c   Hartmann, Annette M ^a   Giegling, Ina ^a   Möller, Hans Jürgen ^a   Quednow, Boris B ^d   Rujescu, Dan ^a   Kumari, Veena ^c,e   Ettinger, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Gerontopsychiatrie und Neurologie   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acoustic startle response; dopamine; DRD2; prepulse inhibition; Taq1a

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; ALLELE; ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; MOLECULAR GENETICS; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING; SINGLE NUCLEOTIDE POLYMORPHISM; AUDITORY STIMULATION; GENETICS; METHODOLOGY; SIGNAL TRANSDUCTION;

ACOUSTIC STIMULATION; ADULT; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; SENSORY GATING; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84867261885     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001787     Document Type: Article

References (88)

1. Aasen I, Kolli L, Kumari V (2005). Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. Journal of Psychopharmacology 19, 39-45.
2. Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1998). Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. Journal of Psychopharmacology 12, 239-245.
3. Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1999). Effects of bromocriptine and haloperidol on prepulse inhibition : comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. Journal of Psychopharmacology 13, 3-9.
4. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, et al. (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA 97, 8104-8109.
5. Ackenheil M, Stotz G, Dietz-Bauer R, Vossen A (1999). Mini International Interview-German version 5.0.0. Mü nchen: Psychiatrische Universitätsklinik Mü nchen.
6. Anokhin AP, Heath AC, Myers E, Ralano A, et al. (2003). Genetic influences on prepulse inhibition of startle reflex in humans. Neuroscience Letters 353, 45-48.
7. Braff DL, Geyer MA, Light GA, Sprock J, et al. (2001). Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophrenia Research 49, 171-178.
8. Braff DL, Stone C, Callaway E, Geyer M, et al. (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15, 339-343.
9. Braff DL, Swerdlow NR, Geyer MA (1999). Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. American Journal of Psychiatry 156, 596-602.
10. Brody AL, Olmstead RE, London ED, Farahi J, et al. (2004). Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry 161, 1211-1218.
11. Cadenhead KS, Geyer MA, Braff DL (1993). Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. American Journal of Psychiatry 150, 1862-1867.
12. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, et al. (2000). Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder : evidence of inhibitory deficits. American Journal of Psychiatry 157, 1660-1668.
13. Campbell LE, Hughes M, Budd TW, Cooper G, et al. (2007). Primary and secondary neural networks of auditory prepulse inhibition : a functional magnetic resonance imaging study of sensorimotor gating of the human acoustic startle response. European Journal of Neuroscience 26, 2327-2333.
14. Cerasa A, Gioia MC, Tarantino P, Labate A, et al. (2009). The DRD2 TaqIA polymorphism associated with changed midbrain volumes in healthy individuals. Genes, Brain and Behavior 8, 459-463.
15. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, et al. (2007). Replicating genotype-phenotype associations. Nature 447, 655-660.
16. Comings DE, Comings BG, Muhleman D, Dietz G, et al. (1991). The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. Journal of the American Medical Association 266, 1793-1800.
17. Csomor PA, Yee BK, Quednow BB, Stadler RR, et al. (2006). The monotonic dependency of prepulse inhibition of the acoustic startle reflex on the intensity of the startle-eliciting stimulus. Behavioural Brain Research 174, 143-150.
18. Csomor PA, Yee BK, Vollenweider FX, Feldon J, et al. (2008). On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behavioral Neuroscience 122, 885-900.
19. Dubertret C, Bardel C, Ramoz N, Martin PM, et al. (2010). A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34, 492-499.
20. Dubertret C, Gorwood P, Gouya L, Deybach JC, et al. (2001). Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophrenia Research 49, 203-212.
21. Dubertret C, Gouya L, Hanoun N, Deybach JC, et al. (2004). The 3k region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophrenia Research 67, 75-85.
22. Dulawa SC, Geyer MA (2000). Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39, 2170-2179.
23. Fendt M, Li L, Yeomans JS (2001). Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology 156, 216-224.
24. Filion DL, Dawson ME, Schell AM (1993). Modification of the acoustic startle-reflex eyeblink : a tool for investigating early and late attentional processes. Biological Psychology 35, 185-200.
25. Fukui N, Suzuki Y, Sugai T, Watanabe J, et al. (2010). Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects. Molecular Psychiatry 16, 356-358.
26. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990). Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Research Bulletin 25, 485-498.
27. Golimbet VE, Aksenova MG, Nosikov VV, Orlova VA, et al. (2003). Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings. Neuroscience and Behavioral Physiology 33, 223-225.
28. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry : etymology and strategic intentions. American Journal of Psychiatry 160, 636-645.
29. Graham FK (1975). The more or less startling effects of weak prestimulation. Psychophysiology 12, 238-248.
30. Grandy DK, Zhang Y, Civelli O (1993). PCR detection of the TaqA RFLP at the DRD2 locus. Human Molecular Genetics 2, 2197.
31. Grattan DR, Kokay IC (2008). Prolactin : a pleiotropic neuroendocrine hormone. Journal of Neuroendocrinology 20, 752-763.
32. Greenwood TA, Braff DL, Light GA, Cadenhead KS, et al. (2007). Initial heritability analyses of endophenotypic measures for schizophrenia : the consortium on the genetics of schizophrenia. Archives of General Psychiatry 64, 1242-1250.
33. Haff LA, Smirnov IP (1997). Single-nucleotide polymorphism identification assays using a thermostable DNA polymerase and delayed extraction MALDI-TOF mass spectrometry. Genome Research 7, 378-388.
34. Hamidovic A, Dlugos A, Skol A, Palmer AA, et al. (2009). Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking : an exploratory study with d-amphetamine in healthy participants. Experimental and Clinical Psychopharmacology 17, 374-383.
35. Hart S, Zreik M, Carper R, Swerdlow NR (1998). Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency. Pharmacology Biochemistry and Behavior 61, 113-119.
36. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991). The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. British Journal of Addiction 86, 1119-1127.
37. Hedges LV, Olkin I (1985). Statistical Methods for Meta-Analysis. Orlando, FL: Academic Press.
38. Hirvonen J, van Erp TGM, Huttunen J, Aalto S, et al. (2005). Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry 62, 371-378.
39. Hirvonen MM, Laakso A, Nögren K, Rinne JO, et al. (2009). C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63, 907-912.
40. Hokyo A, Kanazawa T, Uenishi H, Tsutsumi A, et al. (2010). Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B). Psychiatric Genetics 20, 191-198.
41. Hsieh MH, Swerdlow NR, Braff DL (2006). Effects of background and prepulse characteristics on prepulse inhibition and facilitation : implications for neuropsychiatric research. Biological Psychiatry 59, 555-559.
42. Jönsson EG, Nöthen MM, Grünhage F, Farde L, et al. (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry 4, 290-296.
43. Kaiser SA, Soliakov L, Harvey SC, Luetje CW, et al. (1998). Differential inhibition by conotoxin MII of the nicotinic stimulation of [3H] dopamine release from rat striatal synaptosomes and slices. Journal of Neurochemistry 70, 1069-1076.
44. Krauter EE, Leonard DW, Ison JR (1973). Inhibition of human eye blink by brief acoustic stimulus. Journal of Comparative and Physiological Psychology 84, 246-251.
45. Kretschmer BD, Koch M (1998). The ventral pallidum mediates disruption of prepulse inhibition of the acoustic startle response induced by dopamine agonists, but not by NMDA antagonists. Brain Research 798, 204-210.
46. Kumari V, Antonova E, Geyer MA, Ffytche D, et al. (2007). A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. International Journal of Neuropsychopharmacology 10, 463-477.
47. Kumari V, Antonova E, Zachariah E, Galea A, et al. (2005a). Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage 26, 1052-1058.
48. Kumari V, Checkley SA, Gray JA (1996). Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology 128, 54-60.
49. Kumari V, Das M, Zachariah E, Ettinger U, et al. (2005b). Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 42, 588-594.
50. Kumari V, Ettinger U (2005). Prepulse inhibition deficits in schizophrenia : static or amenable to treatment? Trends in Schizophrenia Research 95-117.
51. Kumari V, Gray JA (1999). Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology 141, 11-15.
52. Kumari V, Gray JA, Geyer MA, Ffytche DH, et al. (2003). Neural correlates of tactile prepulse inhibition : a functional MRI study in normal and schizophrenic subjects. Psychiatry Research 122, 99-113.
53. Kumari V, Peters ER, Fannon D, Premkumar P, et al. (2008). Uncontrollable voices and their relationship to gating deficits in schizophrenia. Schizophrenia Research 101, 185.
54. Kumari V, Soni W, Sharma T (1999). Normalization of information processing deficits in schizophrenia with clozapine. American Journal of Psychiatry 156, 1046-1051.
55. Laucht M, Becker K, Frank J, Schmidt MH, et al. (2008). Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. Journal of the American Academy of Child & Adolescent Psychiatry 47, 673-681.
56. Martinez ZA, Oostwegel J, Geyer MA, Ellison GD, et al. (2000). 'Early' and 'Late' effects of sustained haloperidol on apomorphine-and phencyclidine-induced sensorimotor gating deficits. Neuropsychopharmacology 23, 517-527.
57. Monakhov M, Golimbet V, Abramova L, Kaleda V, et al. (2008). Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophrenia Research 100, 302-307.
58. Montag C, Hartmann P, Merz M, Burk C, et al. (2008). D2 receptor density and prepulse inhibition in humans: negative findings from a molecular genetic approach. Behavioural Brain Research 187, 428-432.
59. Neuner I, Stöcker T, Kellermann T, Ermer V, et al. (2010). Electrophysiology meets fMRI: neural correlates of the startle reflex assessed by simultaneous EMG-fMRI data acquisition. Human Brain Mapping 31, 1675-1685.
60. Oeth P, Beaulieu M, Park C, Kosman D, et al. (2005). iPLEX assay: increased plexing efficiency and flexibility for MassARRAY system through single base primer extension with mass-modified terminators (www.sequenom.com; http://128.135.75.36/iPLEXAppNote.pdf). Accessed 10 November 2006.
61. Peng RY, Mansbach RS, Braff DL, Geyer MA (1990). A D-sub-2 dopamine receptor agonist disrupts sensorimotor gating in rats : implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology 3, 211-218.
62. Pierce CA, Block RA, Aguinis H (2004). Cautionary note on reporting eta-squared values from multifactor ANOVA designs. Educational and Psychological Measurement 64, 916-924.
63. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, et al. (1998a). The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molecular Psychiatry 3, 256-260.
64. Pohjalainen T, Rinne JO, Nagren K, SyvAlahti E, et al. (1998b). Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. American Journal of Psychiatry 155, 768-773.
65. Quednow BB, Wagner M, Westheide J, Beckmann K, et al. (2006). Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biological Psychiatry 59, 536.
66. Quednow BB, Frommann I, Berning J, Kühn KU, et al. (2008). Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biological Psychiatry 64, 766-773.
67. Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, et al. (2009). Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-Omethyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biological Psychiatry 66, 614-620.
68. Quednow BB, Wagner M, Mossner R, Maier W, et al. (2010). Sensorimotor gating of schizophrenia patients depends on catechol O-Methyltransferase Val158Met polymorphism. Schizophrenia Bulletin 36, 341-346.
69. Ritchie T, Noble EP (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochemical Research 28, 73-82.
70. Roussos P, Giakoumaki SG, Bitsios P (2008a). The dopamine D3 receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex. Biological Psychiatry 64, 235-240.
71. Roussos P, Giakoumaki SG, Rogdaki M, Pavlakis S, et al. (2008b). Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism. Psychological Medicine 38, 1651-1658.
72. Schultz W (2002). Getting formal with dopamine and reward. Neuron 36, 241-263.
73. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, et al. (1993). Men are more inhibited than women by weak prepulses. Biological Psychiatry 34, 253-260.
74. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994). Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry 51, 139-154.
75. Swerdlow NR, Eastvold A, Karban B, Ploum Y, et al. (2002a). Dopamine agonist effects on startle and sensorimotor gating in normal male subjects : time course studies. Psychopharmacology 161, 189-201.
76. Swerdlow NR, Geyer MA (1993). Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacology Biochemistry and Behavior 44, 741-744.
77. Swerdlow NR, Geyer MA (1998). Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin 24, 285-301.
78. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat : current knowledge and future challenges. Psychopharmacology 156, 194-215.
79. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, et al. (2006). Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry 63, 1325-1335.
80. Swerdlow NR, Stephany N, Shoemaker JM, Ross L, et al. (2002b). Effects of amantadine and bromocriptine on startle and sensorimotor gating : parametric studies and cross-species comparisons. Psychopharmacology 164, 82-92.
81. Swerdlow NR, Weber M, Qu Y, Light GA, et al. (2008). Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 199, 331-388.
82. The International HapMap Consortium (2003). The international hapmap project. Nature 426, 789-796.
83. Thompson J, Thomas N, Singleton A, Piggot M, et al. (1997). D2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics and Genomics 7, 479-484.
84. Vijayan NN, Bhaskaran S, Koshy LV, Natarajan C, et al. (2007). Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behavioral and Brain Functions 3, 34-46.
85. Whitlock MC (2005). Combining probability from independent tests : the weighted Z method is superior to Fisher's approach. Journal of Evolutionary Biology 18, 1368-1373.
86. Willott JF, Tanner L, O'Steen J, Johnson KR, et al. (2003). Acoustic startle and prepulse inhibition in 40 inbred strains of mice. Behavioral Neuroscience 117, 716-726.
87. Wonnacott S, Kaiser S, Mogg A, Soliakov L, et al. (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. European Journal of Pharmacology 393, 51-58.
88. Yee BK, Chang T, Pietropaolo S, Feldon J (2005). The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6/J mice. Behavioural Brain Research 163, 265-276.